1. asheymommy
2. marz11
3. dynamichealthsol
4. franciscaguila78
5. badaleyes
1.dynamichealthsol 02/02/2018
Beats EPS estimates by $0.04.
2.badaleyes 02/02/2018
Big news - Sees FY18 revs $41.2-42.7 bln vs $41.10 bln
3.asheymommy 01/26/2018
today > $MRK - CHMP gave positive opinions for three medicines to treat type 2 diabetes: Segluromet (ertugliflozin / metform…
4.asheymommy 03/01/2018
5.franciscaguila78 05/04/2018
Moderna and Merck Expand mRNA Cancer Vaccines Collaboration
6.dynamichealthsol 01/03/2018
er details
7.marz11 04/10/2018
Merck monotherapy met primary endpoint in phase 3 keynote-042 study, significantly improving OS as first-line…
8.badaleyes 05/03/2018
Merck Phase 3 KEYNOTE-407 trial investigating KEYTRUDA meets secondary endpoint
9.franciscaguila78 06/25/2018
FDA accepts supplemental biologics license application for Merck’s KEYTRUDA
10.marz11 06/25/2018
Presents new data for Sitagliptin Program with JANUVIA
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW